Axsome Therapeutics, Inc. (AXSM)

206.68 -1.67 (-0.80%) USD  |  NASDAQ  |  Sep 04, 16:00
206.96 +0.28 (+0.14%) After-Hours: 20:00
More

Axsome Therapeutics Annual EPS GAAP Estimates

Annual EPS GAAP Estimates Chart

View Annual EPS GAAP Estimates for AXSM.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual EPS GAAP Estimates Chart
Start Trial

Historical Annual EPS GAAP Estimates Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2028 --
December 31, 2027 --
December 31, 2026 --
Date Value
December 31, 2025 --
December 31, 2024 --

Annual EPS GAAP Estimates Range, Past 5 Years

View Annual EPS GAAP Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual EPS GAAP Estimates Benchmarks

View Annual EPS GAAP Estimates Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Liquidia Corp. Upgrade
Filana Therapeutics, Inc. Upgrade
CorMedix, Inc. Upgrade
Eloxx Pharmaceuticals, Inc. Upgrade